Better care begins with better insight.

Pulmonary embolism (PE) is a leading cause of cardiovascular death in the European Union. Despite its severity, PE is a is a mismanaged unmet medical need. It is frequently underdiagnosed, particularly in high-risk patients, resulting into treatment delays and poor clinical outcomes.

Product demo

Latest News

View all →

Pulmonary Embolism (PE) is a mismanaged unmet medical need

3rd

Leading cause of cardiovascular death in worldwide

100,000+

Preventable deaths per year in Europe

30%

Mortality if undiagnosed or untreated

30%

Of survivors are readmitted to hospial within 1 year

Up to €5869

Direct costs per patient hospitalization

€3.5Bn+

Hospital costs annually in Europe

*Replace with citations / footnotes.

Turning complex cases into clear paths

Our proof of concept aims to confirm that our solution assists physicians in their decision-making process for managing PE.

iHealthyPath — PE

iHealthyPath — PE

Is an AI-powered clinical decision support system (CDSS) for PE management; lowering hospital burden and costs, and improving patient care. It aims to address these challenges by exploring how multimodal AI/ML solutions can offer more accurate diagnostic and prognostic insights, reduce clinical workloads and ultimately improve patient outcomes in PE management.

Our Solution Prototype Features

Pulmonary Embolism Response Teams Dashboard

Unified interface to manage patients with Pulmonary Embolism across physicians especialties and care settings.

Early Detection of Pulmonary Embolism

identifies potential pulmonary embolisms at their earliest signs, triggering timely alerts so physicians can act before the condition becomes critical to enable early intervention and preventing life-threatening complications.

Prognosis

Forecasting patient outcomes through AI-driven insights that help physicians anticipate complications and guide treatment decisions.

Risk Analytics

Quantify and understand each patient’s risk by analyzing key factors, such as smoking history or recent surgery, to support personalized care.

Evidence Based Insights

Deliver clear, evidence-backed guidance that explains the “why” and “what now” behind every AI output to turn predictions into actionable clinical decisions.

Continuous Learning

Leverages real-world feedback from clinical practice to continuously refine its algorithms, ensuring ever-improving performance, adaptability, and trust in evolving hospital environments.

Leadership and advisors

Abel Díaz Berenguer headshot

Abel Díaz Berenguer

CTO

Senior AI/ML Researcher Engineer at ETRO‑VUB

Visionary – Impact‑Driven – Agile

Hichem Sahli headshot

Hichem Sahli

CEO | CSO

Prof at ETRO‑VUB | Principal scientist at IMEC

Strategic Leadership

Interdisciplinary – Innovator – Visionary – Impactful

Arne Pauwels headshot

Arne Pauwels

Business Growth Advisor

Spin‑off coach & management at VUB

Nikos Deligiannis headshot

Nikos Deligiannis

Principal Scientific

Professor at ETRO‑VUB | Senior SP/AI/ML scientist at IMEC | ERC Grantee

Koenraad Nieboer headshot

Koenraad Nieboer

Medical Expert

Professor at VUB | Senior Staff Member, Emergency Radiology at UzB

Enrique Vega headshot

Enrique Vega

Business Development Advisor

CEO & Co‑Founder at Azalea Vision

Become a pilot site

Work with us to co‑design workflows, validate outcomes, and scale safely.